Assessment of significant benefit for orphan medicinal products by European regulators may support subsequent relative effectiveness assessments by health technology assessment organizations
Titel:
Assessment of significant benefit for orphan medicinal products by European regulators may support subsequent relative effectiveness assessments by health technology assessment organizations
Auteur:
Vreman, Rick A. de Ruijter, Angela S. Zawada, Anna Tafuri, Giovanni Stoyanova-Beninska, Violeta O’Connor, Daniel Naumann-Winter, Frauke Wolter, Franziska Mantel-Teeuwisse, Aukje K. Leufkens, Hubert G.M. Sidiropoulos, Iordanis Larsson, Kristina Goettsch, Wim G.